Evidence map›Paper›PMID 42683198›Full record

ReviewDrug design, development and therapy2026

Natural Medicines Modulating Tumor Perineural Invasion: Regulatory Mechanisms and Therapeutic Potential.

Yuanzheng Qiao, Mengting Hou, Yilong Zhou, Qiong Cheng

Abstract readReview
In one paragraph

Review in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuanzheng QiaoJiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Ministry of Education, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu, 226001, People's Republic of China.
Mengting HouJiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Ministry of Education, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu, 226001, People's Republic of China.
Yilong ZhouJiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Ministry of Education, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu, 226001, People's Republic of China.ORCID 0000-0003-2793-1131
Qiong ChengJiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Ministry of Education, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu, 226001, People's Republic of China.ORCID 0000-0002-0209-9361

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perineural invasion (PNI) is a critical pathological hallmark of multiple solid malignancies, which drives tumor progression, distant metastasis, intractable clinical symptoms and poor patient prognosis. Complex tumor-nerve crosstalk and sophisticated molecular networks greatly limit the development of targeted anti-PNI therapies. Natural medicines, featured by structural diversity, multi-target regulatory properties and generally favorable safety profiles, have attracted extensive attention for their potential to disrupt PNI-related signaling and malignant tumor-nerve interactions. This review systematically summarizes representative plant-derived and animal-derived natural compounds with reported anti-invasive or anti-migratory activities relevant to PNI, and comprehensively elaborates their multifaceted mechanisms, including PNI-associated signaling modulation, tumor microenvironment remodeling, inhibition of tumor cell adhesion to and migration along nerves, regulation of tumor proliferation and apoptosis, as well as neural microenvironment homeostasis maintenance. Notably, most available evidence is derived from conventional migration, invasion, or EMT assays rather than PNI-specific experimental models; direct evidence from nerve-tumor co-culture systems or in vivo PNI models remains limited, and no clinical data have been reported to date. The current challenges in this field and prospective directions for further basic research and clinical translation are also highlighted. This review intends to offer theoretical references and rational clues for the development of natural medicines-based anti-PNI therapeutic strategies, while emphasizing the need for rigorous validation in PNI-specific preclinical models and eventual clinical investigation.

Indexed as

Antineoplastic AgentsBiological ProductsNeoplasmsAnimalsCell MovementHumansNeoplasm InvasivenessTumor MicroenvironmentAntineoplastic AgentsBiological Productsmalignanciesnatural medicinesperineural invasiontumor microenvironmenttumor-nerve crosstalk

Identifiers

PMID42683198
PMCPMC13532660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.